Phase 1 Postmenopausal Women Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers
Healthy Postmenopausal Women
Kashiv BioSciences, LLC40 enrolled2 locationsNCT06995482
Recruiting
Phase 1
A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women
Healthy Postmenopausal Women
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.56 enrolled1 locationNCT07118085
Completed
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of KER-012 Administered to Healthy, Postmenopausal Women
Healthy Postmenopausal Women
Keros Therapeutics, Inc.80 enrolled2 locationsACTRN12621001077853
Terminated
Phase 1
Single-ascending dose of CEP 37251 in Healthy Postmenopausal Women
Osteoporosis in Healthy Postmenopausal Women
Cephalon, Inc.54 enrolled1 locationACTRN12610000379011
Completed
Phase 1
A pharmacokinetic study to assess the comparative bioavailability of 17-B-estradiol from Metered-Dose Transdermal Sprays (MDTS) and Estraderm 50 patches as hormone replacement therapy in postmenopausal women.
Hormone replacement therapy in postmenopausal women
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd12 enrolled1 locationACTRN12605000468628